The case for cross-over trials in phase III
Stat Med
.
1997 Sep 15;16(17):2021-2.
doi: 10.1002/(sici)1097-0258(19970915)16:17<2021::aid-sim644>3.0.co;2-e.
Author
S Senn
PMID:
9304771
DOI:
10.1002/(sici)1097-0258(19970915)16:17<2021::aid-sim644>3.0.co;2-e
No abstract available
Publication types
Comment
Letter
MeSH terms
Clinical Trials, Phase III as Topic / methods*
Cross-Over Studies*
Humans
Random Allocation
Research Design